These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37209019)

  • 1. Expression pattern of long non-coding RNAs MALAT1 and MEG3 in COVID-19 patients.
    Genena SESR; Fadhil MM; Mansour MM; Attwa AHM; Khalil MMIM
    J Gene Med; 2023 Sep; 25(9):e3532. PubMed ID: 37209019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lnc-MEG3 acts as a potential biomarker for predicting increased disease risk, systemic inflammation, disease severity, and poor prognosis of sepsis via interacting with miR-21.
    Na L; Ding H; Xing E; Gao J; Liu B; Wang H; Yu J; Yu C
    J Clin Lab Anal; 2020 Apr; 34(4):e23123. PubMed ID: 31907972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of long non-coding RNA maternally expressed gene 3 with microRNA-21 and their correlation with acute ischemic stroke risk, disease severity and recurrence risk.
    Liu C; Huang H; Li Y; Zhao H
    Clin Neurol Neurosurg; 2021 Nov; 210():106940. PubMed ID: 34607195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA MEG3 as a candidate prognostic factor for induction therapy response and survival profile in childhood acute lymphoblastic leukemia patients.
    Gao W
    Scand J Clin Lab Invest; 2021 May; 81(3):194-200. PubMed ID: 33600264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA MALAT1/microRNA 125a axis presents excellent value in discriminating sepsis patients and exhibits positive association with general disease severity, organ injury, inflammation level, and mortality in sepsis patients.
    Liu W; Geng F; Yu L
    J Clin Lab Anal; 2020 Jun; 34(6):e23222. PubMed ID: 32309886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of circulating long non-coding RNA MALAT1 in diagnosis, disease surveillance, and prognosis of acute ischemic stroke.
    Ren H; Wu F; Liu B; Song Z; Qu D
    Braz J Med Biol Res; 2020; 53(12):e9174. PubMed ID: 33111743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Expression of Infection-Related Long Noncoding RNAs among COVID-19 Patients: A Case-Control Study.
    Firoozi Z; Mohammadisoleimani E; Bagheri F; Taheri A; Pezeshki B; Naghizadeh MM; Daraei A; Karimi J; Gholampour Y; Mansoori Y; Montaseri Z
    Genet Res (Camb); 2024; 2024():3391054. PubMed ID: 38389521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of long non coding maternally expressed gene 3 in pediatric acute myeloid leukemia.
    Xue H; Gao H; Xia H; Li S; Li N; Duan Y; Ren Y; Zhang H; Liu J; Gao W
    Medicine (Baltimore); 2021 Sep; 100(35):e26959. PubMed ID: 34477125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNAs TUG1 and MEG3 in patients with type 2 diabetes and their association with endoplasmic reticulum stress markers.
    Heydari N; Sharifi R; Nourbakhsh M; Golpour P; Nourbakhsh M
    J Endocrinol Invest; 2023 Jul; 46(7):1441-1448. PubMed ID: 36662419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of long non-coding RNA MALAT1 correlates with raised acute respiratory distress syndrome risk, disease severity, and increased mortality in sepstic patients.
    Huang X; Zhao M
    Int J Clin Exp Pathol; 2019; 12(5):1877-1887. PubMed ID: 31934011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNAs, MALAT1 and lnc-DC as potential biomarkers for multiple sclerosis diagnosis.
    Shaker OG; Mahmoud RH; Abdelaleem OO; Ibrahem EG; Mohamed AA; Zaki OM; Abdelghaffar NK; Ahmed TI; Hemeda NF; Ahmed NA; Mansour DF
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30514825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of clinically relevant serum proteins as biomarkers for monitoring COVID-19 severity, and end-organ damage among hospitalized unvaccinated patients.
    Elhommosani MR; Sakr MM; Abbas RM; Aboshanab KM
    BMC Infect Dis; 2024 Feb; 24(1):231. PubMed ID: 38378528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Lnc-RNAs in the Pathogenesis and Development of Diabetic Retinopathy.
    Perisset S; Potilinski MC; Gallo JE
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNAs ANRIL, THRIL, and NEAT1 as potential circulating biomarkers of SARS-CoV-2 infection and disease severity.
    Rahni Z; Hosseini SM; Shahrokh S; Saeedi Niasar M; Shoraka S; Mirjalali H; Nazemalhosseini-Mojarad E; Rostami-Nejad M; Malekpour H; Zali MR; Mohebbi SR
    Virus Res; 2023 Oct; 336():199214. PubMed ID: 37657511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Non-coding RNA MALAT1 Inhibits Neuron Apoptosis and Neuroinflammation While Stimulates Neurite Outgrowth and Its Correlation With MiR-125b Mediates PTGS2, CDK5 and FOXQ1 in Alzheimer's Disease.
    Ma P; Li Y; Zhang W; Fang F; Sun J; Liu M; Li K; Dong L
    Curr Alzheimer Res; 2019; 16(7):596-612. PubMed ID: 31345147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Non-Coding RNA MALAT1 Protects Human Osteoblasts from Dexamethasone-Induced Injury via Activation of PPM1E-AMPK Signaling.
    Fan JB; Zhang Y; Liu W; Zhu XH; Xu DW; Zhao JN; Cui ZM
    Cell Physiol Biochem; 2018; 51(1):31-45. PubMed ID: 30439702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel circulating biomarker lnc-MALAT1 for acute myocardial infarction: Its relationship with disease risk, features, cytokines, and major adverse cardiovascular events.
    Li R; Jin J; Liu E; Zhang J
    J Clin Lab Anal; 2022 Dec; 36(12):e24771. PubMed ID: 36378551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA MALAT1 and its target microRNA-125b associate with disease risk, severity, and major adverse cardiovascular event of coronary heart disease.
    Lv F; Liu L; Feng Q; Yang X
    J Clin Lab Anal; 2021 Apr; 35(4):e23593. PubMed ID: 33660877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study.
    Infante M; Buoso A; Pieri M; Lupisella S; Nuccetelli M; Bernardini S; Fabbri A; Iannetta M; Andreoni M; Colizzi V; Morello M
    J Am Nutr Assoc; 2022; 41(3):250-265. PubMed ID: 33600292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological and biochemical biomarker alterations among SARS-COV-2 patients with varying disease phenotypes in Uganda.
    Kato CD; Nsubuga J; Niyonzima N; Kitibwa A; Matovu E; Othieno E; Ssebugere P; Tumwine AA; Namayanja M
    BMC Infect Dis; 2023 Dec; 23(1):857. PubMed ID: 38057707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.